RECLAIM: Retrospective Evaluation of Clinical and Radiographic Outcomes Following Total Talus Replacement

Sponsor
Restor3D (Industry)
Overall Status
Recruiting
CT.gov ID
NCT05231304
Collaborator
(none)
175
3
8.9
58.3
6.6

Study Details

Study Description

Brief Summary

This study is a retrospective analysis of patients who underwent surgery using a total talus replacement (TTR) implant with or without concurrent total ankle replacement and/or subtalar fusion. This study seeks to analyze the clinical and radiographic outcomes of TTR implant recipients and generate additional data on the safety and benefit of the TTR implant.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Total Talus Replacement (TTR)
  • Procedure: Total Ankle Total Talus Replacement (TATTR)
  • Procedure: Total Ankle Total Talus Replacement + Subtalar Fusion (TATTR + STJ)
  • Procedure: Total Talus Replacement + Subtalar Fusion (TTR + STJ)

Study Design

Study Type:
Observational
Anticipated Enrollment :
175 participants
Observational Model:
Case-Crossover
Time Perspective:
Retrospective
Official Title:
Retrospective Evaluation of Clinical and Radiographic Outcomes Following Total Talus Replacement
Actual Study Start Date :
Apr 5, 2022
Anticipated Primary Completion Date :
Oct 1, 2022
Anticipated Study Completion Date :
Jan 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Total Talus Replacement

Procedure: Total Talus Replacement (TTR)
Surgical implantation of restor3d's patient-specific custom Total Talus Replacement device.

Total Ankle Total Talus Replacement

Procedure: Total Ankle Total Talus Replacement (TATTR)
Surgical implantation of restor3d's patient-specific custom Total Ankle Total Talus Replacement (TATTR) device.

Total Ankle Total Talus Replacement + Subtalar Fusion

Procedure: Total Ankle Total Talus Replacement + Subtalar Fusion (TATTR + STJ)
Surgical implantation of restor3d's patient-specific custom Total Ankle Total Talus Replacement (TATTR) device with concurrent subtalar fusion.

Total Talus Replacement + Subtalar Fusion

Procedure: Total Talus Replacement + Subtalar Fusion (TTR + STJ)
Surgical implantation of restor3d's patient-specific custom Total Talus Replacement (TTR) device with concurrent subtalar fusion.

Outcome Measures

Primary Outcome Measures

  1. Improvement in pain from pre-operative baseline [12-months]

    Primary probable benefit endpoint is improvement in pain at 12 months from preoperative baseline.

Secondary Outcome Measures

  1. Improvement in Patient Reported Outcomes [3 months]

    Secondary probably benefit endpoints will include patient reported functional outcome measures

  2. Improvement in Patient Reported Outcomes [6 months]

    Secondary probably benefit endpoints will include patient reported functional outcome measures

  3. Improvement in Patient Reported Outcomes [12 months]

    Secondary probably benefit endpoints will include patient reported functional outcome measures

  4. Improvement in Patient Reported Outcomes [24 months]

    Secondary probably benefit endpoints will include patient reported functional outcome measures

  5. Improvement in Patient Reported Outcomes [36 months]

    Secondary probably benefit endpoints will include patient reported functional outcome measures

Other Outcome Measures

  1. Subsequent Surgical Intervention [Up to 3 years.]

    The primary safety outcome measure is rate of subsequent surgical intervention (SSI), as defined as any surgical procedure or service required after the initial implant of the TTR device.

  2. Adverse Events (AEs)/Serious Adverse Events (SAEs) [Up to 3 years.]

    Safety outcome measures by occurrence of adverse events (AEs), device- or procedure related AEs, and serious AEs.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18 Years of Age

  • Patient underwent surgery involving a total talus replacement implant between 1/1/2019 and 01/28/2022.

Exclusion Criteria:
  • No available postoperative data

Contacts and Locations

Locations

Site City State Country Postal Code
1 Phoenix Foot and Ankle Institute Phoenix Arizona United States 85251
2 Orthopaedic Institute of Western Kentucky Paducah Kentucky United States 42001
3 The Bellevue Hospital Bellevue Ohio United States 44811

Sponsors and Collaborators

  • Restor3D

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Restor3D
ClinicalTrials.gov Identifier:
NCT05231304
Other Study ID Numbers:
  • restor3d-002
First Posted:
Feb 9, 2022
Last Update Posted:
Jun 2, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Restor3D
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 2, 2022